Form 8-K - Current report:
SEC Accession No. 0001564590-22-020081
Filing Date
2022-05-13
Accepted
2022-05-13 14:17:37
Documents
49
Period of Report
2022-05-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K eypt-8k_20220513.htm   iXBRL 8-K 36655
2 EX-99.1 eypt-ex991_95.htm EX-99.1 29890
3 GRAPHIC slide-eoxsbenio2x.jpg GRAPHIC 274615
4 GRAPHIC slide-dya22dve0xe.jpg GRAPHIC 231999
5 GRAPHIC slide-w0n1xl1dgwc.jpg GRAPHIC 281470
6 GRAPHIC slide-oaoop3nprsx.jpg GRAPHIC 327583
7 GRAPHIC slide-5rhwf1dzrbm.jpg GRAPHIC 469771
8 GRAPHIC slide-0jxmcs1m4as.jpg GRAPHIC 367670
9 GRAPHIC slide-yfucjlvdods.jpg GRAPHIC 270505
10 GRAPHIC slide-rxmr0pwqn2v.jpg GRAPHIC 304229
11 GRAPHIC slide-xden0yeetp1.jpg GRAPHIC 230944
12 GRAPHIC slide-taqctr2yorl.jpg GRAPHIC 382344
13 GRAPHIC slide-kaozcuxplrh.jpg GRAPHIC 551002
14 GRAPHIC slide-gaqmthhpyqe.jpg GRAPHIC 438823
15 GRAPHIC slide-zpeue4lucje.jpg GRAPHIC 321994
16 GRAPHIC slide-usxl31gwju4.jpg GRAPHIC 238595
17 GRAPHIC slide-ib0ouyfbjoi.jpg GRAPHIC 261231
18 GRAPHIC slide-n5e0uzpzitr.jpg GRAPHIC 308168
19 GRAPHIC slide-lpwao0p5jd0.jpg GRAPHIC 413712
20 GRAPHIC slide-34yu4ntqtxg.jpg GRAPHIC 308373
21 GRAPHIC slide-2w4e2wxbgbe.jpg GRAPHIC 302881
22 GRAPHIC slide-xnnyukhiy3v.jpg GRAPHIC 435735
23 GRAPHIC slide-dnfgt4lei2j.jpg GRAPHIC 412332
24 GRAPHIC slide-mvosdy0tqjx.jpg GRAPHIC 307099
25 GRAPHIC slide-zd5fil3fomx.jpg GRAPHIC 539825
26 GRAPHIC slide-cmle2moe4ae.jpg GRAPHIC 408910
27 GRAPHIC slide-okyggv1ivks.jpg GRAPHIC 335373
28 GRAPHIC slide-mveyhqgfc2o.jpg GRAPHIC 348180
29 GRAPHIC slide-kab0gpp2had.jpg GRAPHIC 264599
30 GRAPHIC slide-l4kvi2nnios.jpg GRAPHIC 310443
31 GRAPHIC slide-lusuycr3ctd.jpg GRAPHIC 542638
32 GRAPHIC slide-zganfln501m.jpg GRAPHIC 322362
33 GRAPHIC slide-l02lcfsdcia.jpg GRAPHIC 255548
34 GRAPHIC slide-qgbc23ovyno.jpg GRAPHIC 385959
35 GRAPHIC slide-mtrzxhchtwl.jpg GRAPHIC 235969
36 GRAPHIC slide-ckvjdcmujht.jpg GRAPHIC 324929
37 GRAPHIC slide-wmvhey1bsda.jpg GRAPHIC 433023
38 GRAPHIC slide-2a4ttkqejfv.jpg GRAPHIC 234182
  Complete submission text file 0001564590-22-020081.txt   17261851

Data Files

Seq Description Document Type Size
39 XBRL TAXONOMY EXTENSION SCHEMA eypt-20220513.xsd EX-101.SCH 5597
40 XBRL TAXONOMY EXTENSION LABEL LINKBASE eypt-20220513_lab.xml EX-101.LAB 18574
41 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eypt-20220513_pre.xml EX-101.PRE 11041
43 EXTRACTED XBRL INSTANCE DOCUMENT eypt-8k_20220513_htm.xml XML 3415
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

EIN.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51122 | Film No.: 22921868
SIC: 3826 Laboratory Analytical Instruments